Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

This publication has 19 references indexed in Scilit:

• Hepatocyte growth factor gene therapy of liver cirrhosis in rats
  Nature Medicine, 1999
• Atherosclerosis — An Inflammatory Disease
  New England Journal of Medicine, 1999
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
  Nature, 1998
• Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
  Molecular Cell, 1998
• Chemokines
  Blood, 1997
• Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
  Journal of Clinical Investigation, 1997
• A Dominant Negative Inhibitor Indicates that Monocyte Chemoattractant Protein 1 Functions as a Dimer
  Molecular and Cellular Biology, 1995
• Molecular Bases of the Acute Coronary Syndromes
  Circulation, 1995
• Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody
  Human Pathology, 1993
• Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
  Proceedings of the National Academy of Sciences, 1991